2BBBullish & Bearish
Health Care

SELLAS Life Sciences Group, Inc. (SLS) Stock Score & Signals

SELLAS Life Sciences Group, Inc. (SLS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 6 out of 100.

2BB score and signals

SELLAS Life Sciences Group, Inc.’s current 2BB score is 6 out of 100, built from the signal categories below.

SignalScoreReading
Activity0Very Low
Momentum50Stable
Financial strength0Very Weak
Quality40Normal
Risk40Low

Company facts

CEOAngelos M. Stergiou
Founded2006
Employees13
52-week range$1.39 – $15.88

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2026-11-10—-0.0505——
2026-08-10—-0.0455——
2026-05-12-0.05-0.0404——
2026-03-19-0.05-0.0657$0.00—